evolving paradigms of hormone receptor-positive breast cancer: the rise of antibody-drug conjugates
Published 3 months ago • 5 plays • Length 1:11:01Download video MP4
Download video MP3
Similar videos
-
18:25
emerging antibody-drug conjugates in breast cancer: an expert analysis of promising therapies
-
1:15:47
evolving landscape of hr-positive metastatic breast cancer: a year in review
-
37:59
antibody-drug conjugates in the spotlight: novel strategies for breast cancer management
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
18:35
managing adverse events of novel antibody-drug conjugates in breast cancer
-
1:21:32
antibody–drug conjugates for solid tumors: progress, possibilities, and implications for care
-
43:25
safety considerations for the development of antibody drug conjugates
-
11:12
her2-low breast cancer: destiny or good science?
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
9:03
prof carlos barrios - 'sequencing of antibody conjugates' and 'metastatic breast cancer treatment'
-
3:59
antibody drug conjugates in breast and gyn cancer
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
0:49
optimizing patient selection for antibody drug conjugates in breast cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
16:46
what are antibody drug conjugates (adcs)? 👀 the newest cancer treatment breakthrough – explained!
-
28:55
part 11 - evolution of antibody drug conjugates in cancer - dr. gail phillips, usa
-
1:33:22
transforming metastatic breast cancer management: harnessing the power of antibody-drug conjugate...
-
0:46
antibody-drug conjugates in gynecological cancers
-
37:53
addressing the challenge of endocrine-resistant breast cancer
-
8:45
how are antibody drug conjugates used to treat breast cancer? all you need to know